What a joke in that artical JPMorgan maintained an underweight recommendation, with a June 2008 price target of $2.70 a share.
Look boys I have been on this one for a while next year there will be an upgrade on it any one seeling will regret it
- Forums
- ASX - By Stock
- OXR
- the age article
OXR
oxiana limited
the age article, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online